Immunomedics, Inc. (IMMU) Analysts See $-0.13 EPS; DIXONS CARPHONE PLC ORDINARY SHARES UNI (DSITF) SI Increased By 2583.33%

April 17, 2018 - By Dolores Ford

Immunomedics, Inc. (NASDAQ:IMMU) Logo

DIXONS CARPHONE PLC ORDINARY SHARES UNI (OTCMKTS:DSITF) had an increase of 2583.33% in short interest. DSITF’s SI was 161,000 shares in April as released by FINRA. Its up 2583.33% from 6,000 shares previously. With 2,000 avg volume, 81 days are for DIXONS CARPHONE PLC ORDINARY SHARES UNI (OTCMKTS:DSITF)’s short sellers to cover DSITF’s short positions. The SI to DIXONS CARPHONE PLC ORDINARY SHARES UNI’s float is 0.02%. It closed at $2.65 lastly. It is down 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts expect Immunomedics, Inc. (NASDAQ:IMMU) to report $-0.13 EPS on May, 9.They anticipate $0.09 EPS change or 40.91% from last quarter’s $-0.22 EPS. After having $-0.19 EPS previously, Immunomedics, Inc.’s analysts see -31.58% EPS growth. The stock increased 2.15% or $0.35 during the last trading session, reaching $16.65. About 647,729 shares traded. Immunomedics, Inc. (NASDAQ:IMMU) has risen 117.70% since April 17, 2017 and is uptrending. It has outperformed by 106.15% the S&P500.

Dixons Carphone plc operates as an electrical and telecommunications retailer and service company. The company has market cap of $2.96 billion. The firm operates through four divisions: UK & Ireland, Nordics, Southern Europe, and Connected World Services . It has a 9.04 P/E ratio. It offers various services and products in the United Kingdom and Ireland, including mobile handsets and other connected devices under the Carphone Warehouse brand; electrical and telecommunications products under the CurrysPCWorld Carphone Warehouse brand; computing services and products to business to business clients under the PC World Business name; travelling services with stores at airports under the Dixons Travel brand; and services under the Knowhow brand, as well as repairs and support services for Carphone Warehouse and Phone House under the Geek Squad brand name.

Investors sentiment decreased to 1.07 in 2017 Q4. Its down 0.58, from 1.65 in 2017Q3. It dropped, as 27 investors sold Immunomedics, Inc. shares while 44 reduced holdings. 29 funds opened positions while 47 raised stakes. 117.18 million shares or 4.91% more from 111.69 million shares in 2017Q3 were reported. Spectrum Mngmt Group Inc holds 0.01% of its portfolio in Immunomedics, Inc. (NASDAQ:IMMU) for 2,500 shares. Moreover, Iguana Healthcare Management Lc has 4.74% invested in Immunomedics, Inc. (NASDAQ:IMMU) for 450,000 shares. Aqr Capital Management Ltd Liability stated it has 0% in Immunomedics, Inc. (NASDAQ:IMMU). Franklin Resource holds 0.01% or 775,800 shares in its portfolio. Rhumbline Advisers reported 0% stake. Ny State Common Retirement Fund has invested 0% in Immunomedics, Inc. (NASDAQ:IMMU). Lpl Fincl Lc owns 13,850 shares for 0% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Immunomedics, Inc. (NASDAQ:IMMU). The Massachusetts-based Panagora Asset Mngmt Inc has invested 0.04% in Immunomedics, Inc. (NASDAQ:IMMU). Vanguard Group Incorporated accumulated 5.38M shares. Amalgamated National Bank has invested 0.01% in Immunomedics, Inc. (NASDAQ:IMMU). Tci Wealth Advisors accumulated 2,000 shares. Vident Inv Advisory Ltd Co invested 0.03% of its portfolio in Immunomedics, Inc. (NASDAQ:IMMU). Orbimed Advsr owns 8.46M shares or 1.73% of their US portfolio. Citigroup invested 0.01% of its portfolio in Immunomedics, Inc. (NASDAQ:IMMU).

Since February 28, 2018, it had 0 buys, and 1 sale for $2.05 million activity. GOLDENBERG DAVID M sold 117,729 shares worth $2.05M.

Among 3 analysts covering Immunomedics (NASDAQ:IMMU), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Immunomedics had 15 analyst reports since July 29, 2015 according to SRatingsIntel. Cowen & Co maintained Immunomedics, Inc. (NASDAQ:IMMU) on Monday, July 24 with “Buy” rating. Jefferies maintained it with “Buy” rating and $16 target in Monday, October 9 report. Jefferies reinitiated the stock with “Buy” rating in Thursday, October 6 report. Wells Fargo downgraded the shares of IMMU in report on Tuesday, June 21 to “Market Perform” rating. The stock of Immunomedics, Inc. (NASDAQ:IMMU) has “Hold” rating given on Tuesday, March 15 by Jefferies. As per Friday, May 6, the company rating was upgraded by Jefferies. As per Wednesday, July 29, the company rating was downgraded by Jefferies. The company was maintained on Wednesday, December 6 by Cowen & Co. On Wednesday, December 6 the stock rating was maintained by Jefferies with “Buy”. Jefferies maintained the shares of IMMU in report on Thursday, August 17 with “Buy” rating.

Immunomedics, Inc. (NASDAQ:IMMU) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts